Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer.
159 employees · est. 2001 · Cambridge, United States
Mersana Therapeutics is the older company (2016 vs 2001).
Side-by-Side Comparison
| Metric | iktos | Mersana Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2001 older |
| Headquarters | ||
| Headquarters | Paris, France | Cambridge, United States |
| Employees | ||
| Employees | 85 | 159 |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Acquired |
| Total Funding | ||
| Total Funding | $18.90M | $534.80M |
| Funding Rounds | ||
| Funding Rounds | 7 | 13 |
| Services | ||
| Services | AI-driven drug discovery platform, Generative AI for molecular design, Retrosynthesis and synthesis planning, Automated synthesis and testing, Biological data integration | Drug Development, Clinical Trials, Patient Resource Support |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotechnology firms, Academic research institutions, Medicinal and computational chemistry teams | Patients with cancer, Healthcare providers, Pharmaceutical partners, Researchers |
| Taxonomy | ||
| Taxonomy | Artificial Intelligence In Drug Discovery, Generative AI For Molecule Design, MedTech SaaS Solutions, Pharmaceutical R&D Productivity, AI-Driven Synthesis Automation, Oncology Drug Development, Auto-Immune Drug Research, Protein-Protein Interaction Targeting, RNA-Protein Interaction Targeting, Chemoinformatics, Machine Learning In Medicinal Chemistry, Robotics In Drug Discovery, Series A Financing, Strategic Pharma Collaborations, Medicinal Chemistry AI | Antibody-Drug Conjugates (ADCs), Cancer Research, Oncology Drug Development, Bioconjugation, Cytotoxic Therapeutics, Immunostimulatory Therapeutics, Biodegradable Polymer Platform, B7-H4 Targeting, HER2 Targeting, Clinical-Stage Biopharmaceuticals |
| Website | ||
| Website | iktos.ai | mersana.com |
About iktos
Iktos, founded in 2016 and headquartered in France, stands at the forefront of leveraging Artificial Intelligence for both medicinal chemistry research and novel drug design. Their slogan, "Artificial intelligence for new drug design," encapsulates their mission. The company offers proprietary SaaS...
About Mersana Therapeutics
Mersana Therapeutics, founded in 2001, is a visionary player in the Biotechnology and Health Care sectors, headquartered in the United States. With its mission, "Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer," the company stands at...
We will tell you when either one moves
BounceWatch watches iktos and Mersana Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at iktos and Mersana Therapeutics — by email.
Frequently Asked Questions
Compare iktos with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at iktos on 20 Aug 2026, and Mersana Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.